These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 20554964)
1. IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail. Ho AW; Shen F; Conti HR; Patel N; Childs EE; Peterson AC; Hernández-Santos N; Kolls JK; Kane LP; Ouyang W; Gaffen SL J Immunol; 2010 Jul; 185(2):1063-70. PubMed ID: 20554964 [TBL] [Abstract][Full Text] [Related]
2. SEF/IL-17R (SEFIR) is not enough: an extended SEFIR domain is required for il-17RA-mediated signal transduction. Onishi RM; Park SJ; Hanel W; Ho AW; Maitra A; Gaffen SL J Biol Chem; 2010 Oct; 285(43):32751-32759. PubMed ID: 20729198 [TBL] [Abstract][Full Text] [Related]
3. A CC' loop decoy peptide blocks the interaction between Act1 and IL-17RA to attenuate IL-17- and IL-25-induced inflammation. Liu C; Swaidani S; Qian W; Kang Z; Sun P; Han Y; Wang C; Gulen MF; Yin W; Zhang C; Fox PL; Aronica M; Hamilton TA; Misra S; Deng J; Li X Sci Signal; 2011 Nov; 4(197):ra72. PubMed ID: 22045852 [TBL] [Abstract][Full Text] [Related]
4. Crystal structure of IL-17 receptor B SEFIR domain. Zhang B; Liu C; Qian W; Han Y; Li X; Deng J J Immunol; 2013 Mar; 190(5):2320-6. PubMed ID: 23355738 [TBL] [Abstract][Full Text] [Related]
5. Structural Analysis Reveals that the Cytokine IL-17F Forms a Homodimeric Complex with Receptor IL-17RC to Drive IL-17RA-Independent Signaling. Goepfert A; Lehmann S; Blank J; Kolbinger F; Rondeau JM Immunity; 2020 Mar; 52(3):499-512.e5. PubMed ID: 32187518 [TBL] [Abstract][Full Text] [Related]
6. Structure of the unique SEFIR domain from human interleukin 17 receptor A reveals a composite ligand-binding site containing a conserved α-helix for Act1 binding and IL-17 signaling. Zhang B; Liu C; Qian W; Han Y; Li X; Deng J Acta Crystallogr D Biol Crystallogr; 2014 May; 70(Pt 5):1476-83. PubMed ID: 24816115 [TBL] [Abstract][Full Text] [Related]
7. IL-17RC is required for IL-17A- and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis. Hu Y; Ota N; Peng I; Refino CJ; Danilenko DM; Caplazi P; Ouyang W J Immunol; 2010 Apr; 184(8):4307-16. PubMed ID: 20231694 [TBL] [Abstract][Full Text] [Related]
8. IL-17RC: a partner in IL-17 signaling and beyond. Ho AW; Gaffen SL Semin Immunopathol; 2010 Mar; 32(1):33-42. PubMed ID: 20012905 [TBL] [Abstract][Full Text] [Related]
10. The anaphase-promoting complex protein 5 (AnapC5) associates with A20 and inhibits IL-17-mediated signal transduction. Ho AW; Garg AV; Monin L; Simpson-Abelson MR; Kinner L; Gaffen SL PLoS One; 2013; 8(7):e70168. PubMed ID: 23922952 [TBL] [Abstract][Full Text] [Related]
11. IL-17A versus IL-17F induced intracellular signal transduction pathways and modulation by IL-17RA and IL-17RC RNA interference in AGS gastric adenocarcinoma cells. Zhou Y; Toh ML; Zrioual S; Miossec P Cytokine; 2007 Jun; 38(3):157-64. PubMed ID: 17644350 [TBL] [Abstract][Full Text] [Related]
12. The IL-17F/IL-17RC Axis Promotes Respiratory Allergy in the Proximal Airways. De Luca A; Pariano M; Cellini B; Costantini C; Villella VR; Jose SS; Palmieri M; Borghi M; Galosi C; Paolicelli G; Maiuri L; Fric J; Zelante T Cell Rep; 2017 Aug; 20(7):1667-1680. PubMed ID: 28813677 [TBL] [Abstract][Full Text] [Related]
13. Signaling through IL-17C/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis. Conti HR; Whibley N; Coleman BM; Garg AV; Jaycox JR; Gaffen SL PLoS One; 2015; 10(4):e0122807. PubMed ID: 25849644 [TBL] [Abstract][Full Text] [Related]
14. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Qian Y; Liu C; Hartupee J; Altuntas CZ; Gulen MF; Jane-Wit D; Xiao J; Lu Y; Giltiay N; Liu J; Kordula T; Zhang QW; Vallance B; Swaidani S; Aronica M; Tuohy VK; Hamilton T; Li X Nat Immunol; 2007 Mar; 8(3):247-56. PubMed ID: 17277779 [TBL] [Abstract][Full Text] [Related]
15. The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex. Wright JF; Bennett F; Li B; Brooks J; Luxenberg DP; Whitters MJ; Tomkinson KN; Fitz LJ; Wolfman NM; Collins M; Dunussi-Joannopoulos K; Chatterjee-Kishore M; Carreno BM J Immunol; 2008 Aug; 181(4):2799-805. PubMed ID: 18684971 [TBL] [Abstract][Full Text] [Related]
16. Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. Kuestner RE; Taft DW; Haran A; Brandt CS; Brender T; Lum K; Harder B; Okada S; Ostrander CD; Kreindler JL; Aujla SJ; Reardon B; Moore M; Shea P; Schreckhise R; Bukowski TR; Presnell S; Guerra-Lewis P; Parrish-Novak J; Ellsworth JL; Jaspers S; Lewis KE; Appleby M; Kolls JK; Rixon M; West JW; Gao Z; Levin SD J Immunol; 2007 Oct; 179(8):5462-73. PubMed ID: 17911633 [TBL] [Abstract][Full Text] [Related]
17. An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis. Boisson B; Wang C; Pedergnana V; Wu L; Cypowyj S; Rybojad M; Belkadi A; Picard C; Abel L; Fieschi C; Puel A; Li X; Casanova JL Immunity; 2013 Oct; 39(4):676-86. PubMed ID: 24120361 [TBL] [Abstract][Full Text] [Related]
18. Molecular characterization and evolution analysis of five interleukin-17 receptor genes in large yellow croaker Larimichthys crocea. Ding Y; Ai C; Mu Y; Ao J; Chen X Fish Shellfish Immunol; 2016 Nov; 58():332-339. PubMed ID: 27633682 [TBL] [Abstract][Full Text] [Related]
19. Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1. Shi P; Zhu S; Lin Y; Liu Y; Liu Y; Chen Z; Shi Y; Qian Y Sci Signal; 2011 Nov; 4(197):ra73. PubMed ID: 22045853 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-17-induced protein lipocalin 2 is dispensable for immunity to oral candidiasis. Ferreira MC; Whibley N; Mamo AJ; Siebenlist U; Chan YR; Gaffen SL Infect Immun; 2014 Mar; 82(3):1030-5. PubMed ID: 24343647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]